(SMMT) Summit Therapeutics - Performance 424.9% in 12m
Compare SMMT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
56.72%
#9 in Group
Rel. Strength
99.61%
#32 in Universe
Total Return 12m
424.89%
#3 in Group
Total Return 5y
727.85%
#3 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -0.82%
49th Percentile in Group
12m Total Return: SMMT (424.9%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: SMMT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SMMT
Total Return (including Dividends) | SMMT | XBI | S&P 500 |
---|---|---|---|
1 Month | 31.22% | 5.55% | -0.45% |
3 Months | 23.47% | -9.75% | -6.29% |
12 Months | 424.89% | -5.39% | 13.04% |
5 Years | 727.85% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | SMMT | XBI | S&P 500 |
1 Month | 67.3% | 70% | 47.5% |
3 Months | 32.0% | -88.1% | -87.3% |
12 Months | 72.7% | -44.4% | 54.3% |
5 Years | 21.4% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #23 | 24.3% | 31.8% |
3 Month | #18 | 36.8% | 31.8% |
12 Month | #4 | 455% | 364% |
5 Years | #3 | 854% | 291% |
FAQs
Does SMMT Summit Therapeutics outperforms the market?
Yes,
over the last 12 months SMMT made 424.89%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months SMMT made 23.47%, while XBI made -9.75%.
Over the last 3 months SMMT made 23.47%, while XBI made -9.75%.
Performance Comparison SMMT vs Indeces and Sectors
SMMT vs. Indices SMMT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -34.9% | 31.7% | 31.5% | 412% |
US NASDAQ 100 | QQQ | -35.9% | 29.3% | 30.8% | 410% |
US Dow Jones Industrial 30 | DIA | -34.4% | 34.1% | 32.3% | 416% |
German DAX 40 | DAX | -34.6% | 31.4% | 13.4% | 400% |
Shanghai Shenzhen CSI 300 | CSI 300 | -31.3% | 34.4% | 35.2% | 420% |
Hongkong Hang Seng | HSI | -34.5% | 32.7% | 31.0% | 412% |
India NIFTY 50 | INDA | -32.4% | 26.3% | 31.6% | 422% |
Brasil Bovespa | EWZ | -33.3% | 28.4% | 25.8% | 432% |
SMMT vs. Sectors SMMT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -35.1% | 31.8% | 25.5% | 401% |
Consumer Discretionary | XLY | -35.0% | 31.8% | 30.3% | 410% |
Consumer Staples | XLP | -32.9% | 32.0% | 27.4% | 414% |
Energy | XLE | -30.7% | 45.3% | 36.6% | 434% |
Financial | XLF | -33.8% | 33.2% | 24.6% | 402% |
Health Care | XLV | -32.2% | 35.9% | 36.7% | 426% |
Industrial | XLI | -35.3% | 30.9% | 30.5% | 414% |
Materials | XLB | -33.1% | 34.4% | 39.3% | 429% |
Real Estate | XLRE | -34.8% | 32.3% | 31.3% | 407% |
Technology | XLK | -36.5% | 28.8% | 34.4% | 414% |
Utilities | XLU | -33.7% | 31.1% | 27.1% | 404% |
Aerospace & Defense | XAR | -36.0% | 24.2% | 17.6% | 397% |
Biotech | XBI | -34.8% | 25.7% | 46.8% | 430% |
Homebuilder | XHB | -33.7% | 33.3% | 46.5% | 431% |
Retail | XRT | -33.7% | 32.4% | 37.5% | 426% |